Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of oxidative stress in ovarian aging: a review. | J Ovarian Res | 2022 | 36050696 | PubTator, text mining | PubMed |
| Comparative genomics of mortal and immortal cnidarians unveils novel keys behind rejuvenation. | Proc Natl Acad Sci U S A | 2022 | 36037356 | PubTator, text mining | PubMed |
| Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells. | J Hematol Oncol | 2022 | 36030273 | PubTator, text mining | PubMed |
| POT1 mutations are frequent and associated with Ki-67 index in canine diffuse large B-cell lymphoma. | Front Vet Sci | 2022 | 36016811 | PubTator, text mining | PubMed |
| Long non‑coding RNAs interact with RNA‑binding proteins to regulate genomic instability in cancer cells (Review). | Oncol Rep | 2022 | 36004472 | PubTator, text mining | PubMed |
| TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer. | Front Oncol | 2022 | 35982970 | PubTator, text mining | PubMed |
| Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers. | Clin Transl Med | 2022 | 35979662 | PubTator, text mining | PubMed |
| GeneHome - a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer. | Cancer Control | 2022 | 35976772 | PubTator, text mining | PubMed |
| Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer. | Cancer Cell Int | 2022 | 35974340 | PubTator, text mining | PubMed |
| [Study of cytogenetics and molecular biology in typical and atypical immunophenotypic chronic lymphocytic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35968589 | PubTator, text mining | PubMed |
| Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL. | Mol Syst Biol | 2022 | 35959629 | PubTator, text mining | PubMed |
| Computational Analysis of Short Linear Motifs in the Spike Protein of SARS-CoV-2 Variants Provides Possible Clues into the Immune Hijack and Evasion Mechanisms of Omicron Variant. | Int J Mol Sci | 2022 | 35955954 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Expression of POT1-AS1 in GC Tissue, Its Effect on Biological Behavior of Gastric Cancer, and Its Significance on Prognosis of Gastric Cancer. | Comput Math Methods Med | 2022 | 35936358 | PubTator, text mining | PubMed |
| Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35935869 | PubTator, text mining | PubMed |
| Helicase mediated vectorial folding of telomere G-quadruplex. | Methods Enzymol | 2022 | 35934479 | PubTator, text mining | PubMed |
| Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. | Am J Hum Genet | 2022 | 35931051 | PubTator, text mining | PubMed |
| Tieing together loose ends: telomere instability in cancer and aging. | Mol Oncol | 2022 | 35920280 | PubTator, text mining | PubMed |
| Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma. | Cancer Commun (Lond) | 2022 | 35920016 | PubTator, text mining | PubMed |
| CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome. | Clin Exp Dermatol | 2022 | 35904890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=25